Anne-Mieke Vandamme
AuthID: R-000-Q27
401
TITLE: Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors.
AUTHORS: Balzarini, J; Karlsson, A; Vandamme, AM; Perez-Perez, MJ; Zhang, H; Vrang, L; Oberg, B; Backbro, K; Unge, T; San-Felix, A;
PUBLISHED: 1993, SOURCE: Proceedings of the National Academy of Sciences, VOLUME: 90, ISSUE: 15
AUTHORS: Balzarini, J; Karlsson, A; Vandamme, AM; Perez-Perez, MJ; Zhang, H; Vrang, L; Oberg, B; Backbro, K; Unge, T; San-Felix, A;
PUBLISHED: 1993, SOURCE: Proceedings of the National Academy of Sciences, VOLUME: 90, ISSUE: 15
402
TITLE: Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.
AUTHORS: Pauwels, R; Andries, K; Debyser, Z; Van Daele, P; Schols, D; Stoffels, P; De Vreese, K; Woestenborghs, R; Vandamme, AM; Janssen, CG;
PUBLISHED: 1993, SOURCE: Proceedings of the National Academy of Sciences, VOLUME: 90, ISSUE: 5
AUTHORS: Pauwels, R; Andries, K; Debyser, Z; Van Daele, P; Schols, D; Stoffels, P; De Vreese, K; Woestenborghs, R; Vandamme, AM; Janssen, CG;
PUBLISHED: 1993, SOURCE: Proceedings of the National Academy of Sciences, VOLUME: 90, ISSUE: 5
403
TITLE: CELL TYPE-SPECIFIC ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY OF THE TRANSACTIVATION INHIBITOR-RO5-3335
AUTHORS: WITVROUW, M; PAUWELS, R; VANDAMME, AM; SCHOLS, D; REYMEN, D; YAMAMOTO, N; DESMYTER, J; DECLERCQ, E;
PUBLISHED: 1992, SOURCE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 36, ISSUE: 12
AUTHORS: WITVROUW, M; PAUWELS, R; VANDAMME, AM; SCHOLS, D; REYMEN, D; YAMAMOTO, N; DESMYTER, J; DECLERCQ, E;
PUBLISHED: 1992, SOURCE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 36, ISSUE: 12
INDEXED IN: 
Scopus 
WOS
Scopus WOS IN MY: 
ORCID | ResearcherID
ORCID | ResearcherID404
TITLE: CHARACTERIZATION OF A RECOMBINANT CHIMERIC PLASMINOGEN-ACTIVATOR COMPOSED OF A FIBRIN FRAGMENT-D-DIMER-SPECIFIC HUMANIZED MONOCLONAL-ANTIBODY AND A TRUNCATED SINGLE-CHAIN UROKINASE
AUTHORS: VANDAMME, AM; DEWERCHIN, M; LIJNEN, HR; BERNAR, H; BULENS, F; NELLES, L; COLLEN, D;
PUBLISHED: 1992, SOURCE: EUROPEAN JOURNAL OF BIOCHEMISTRY, VOLUME: 205, ISSUE: 1
AUTHORS: VANDAMME, AM; DEWERCHIN, M; LIJNEN, HR; BERNAR, H; BULENS, F; NELLES, L; COLLEN, D;
PUBLISHED: 1992, SOURCE: EUROPEAN JOURNAL OF BIOCHEMISTRY, VOLUME: 205, ISSUE: 1
IN MY: ORCID | ResearcherID
ORCID | ResearcherID405
TITLE: 2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-3'-SPIRO-5''-(4''-AMINO-1',2''-OXATHIOLE-2'',2''-DIOXIDE)PYRIMIDINE (TSAO) NUCLEOSIDE ANALOGS - HIGHLY SELECTIVE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 THAT ARE TARGETED AT THE VIRAL REVERSE-TRANSCRIPTASE
AUTHORS: BALZARINI, J; PEREZPEREZ, MJ; SANFELIX, A; SCHOLS, D; PERNO, CF; VANDAMME, AM; CAMARASA, MJ; DECLERCQ, E;
PUBLISHED: 1992, SOURCE: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, VOLUME: 89, ISSUE: 10
AUTHORS: BALZARINI, J; PEREZPEREZ, MJ; SANFELIX, A; SCHOLS, D; PERNO, CF; VANDAMME, AM; CAMARASA, MJ; DECLERCQ, E;
PUBLISHED: 1992, SOURCE: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, VOLUME: 89, ISSUE: 10
INDEXED IN: Scopus WOS
Scopus WOS IN MY: ORCID | ResearcherID
ORCID | ResearcherID406
TITLE: THROMBOLYTIC AND PHARMACOKINETIC PROPERTIES OF A RECOMBINANT CHIMERIC PLASMINOGEN-ACTIVATOR CONSISTING OF A FIBRIN FRAGMENT D-DIMER SPECIFIC HUMANIZED MONOCLONAL-ANTIBODY AND A TRUNCATED SINGLE-CHAIN UROKINASE
AUTHORS: DEWERCHIN, M; VANDAMME, AM; HOLVOET, P; DECOCK, F; LEMMENS, G; LIJNEN, HR; STASSEN, JM; COLLEN, D;
PUBLISHED: 1992, SOURCE: THROMBOSIS AND HAEMOSTASIS, VOLUME: 68, ISSUE: 2
AUTHORS: DEWERCHIN, M; VANDAMME, AM; HOLVOET, P; DECOCK, F; LEMMENS, G; LIJNEN, HR; STASSEN, JM; COLLEN, D;
PUBLISHED: 1992, SOURCE: THROMBOSIS AND HAEMOSTASIS, VOLUME: 68, ISSUE: 2
INDEXED IN: Scopus WOS
Scopus WOS IN MY: ORCID | ResearcherID
ORCID | ResearcherID407
TITLE: RESISTANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE TO TIBO DERIVATIVES INDUCED BY SITE-DIRECTED MUTAGENESIS Full Text
AUTHORS: DEVREESE, K; DEBYSER, Z; VANDAMME, AM; PAUWELS, R; DESMYTER, J; DE CLERCQ, E; ANNE, J;
PUBLISHED: 1992, SOURCE: VIROLOGY, VOLUME: 188, ISSUE: 2
AUTHORS: DEVREESE, K; DEBYSER, Z; VANDAMME, AM; PAUWELS, R; DESMYTER, J; DE CLERCQ, E; ANNE, J;
PUBLISHED: 1992, SOURCE: VIROLOGY, VOLUME: 188, ISSUE: 2
INDEXED IN: Scopus WOS
Scopus WOS IN MY: ORCID | ResearcherID
ORCID | ResearcherID408
TITLE: KINETICS OF INHIBITION OF ENDOGENOUS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE TRANSCRIPTION BY 2',3'-DIDEOXYNUCLEOSIDE 5'-TRIPHOSPHATE, TETRAHYDROIMIDAZO-[4,5,1-JK][1,4]-BENZODIAZEPIN-2(1H)-THIONE, AND 1-[(2-HYDROXYETHOXY)METHYL]-6-(PHENYLTHIO)THYMINE DERIVATIVES
AUTHORS: DEBYSER, Z; VANDAMME, AM; PAUWELS, R; BABA, M; DESMYTER, J; DE CLERCQ, E;
PUBLISHED: 1992, SOURCE: JOURNAL OF BIOLOGICAL CHEMISTRY, VOLUME: 267, ISSUE: 17
AUTHORS: DEBYSER, Z; VANDAMME, AM; PAUWELS, R; BABA, M; DESMYTER, J; DE CLERCQ, E;
PUBLISHED: 1992, SOURCE: JOURNAL OF BIOLOGICAL CHEMISTRY, VOLUME: 267, ISSUE: 17
INDEXED IN: Scopus WOS
Scopus WOS IN MY: ORCID | ResearcherID
ORCID | ResearcherID409
TITLE: 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase.
AUTHORS: Balzarini, J; Perez-Perez, MJ; San-Felix, A; Schols, D; Perno, CF; Vandamme, AM; Camarasa, MJ; De Clercq, E;
PUBLISHED: 1992, SOURCE: Proceedings of the National Academy of Sciences, VOLUME: 89, ISSUE: 10
AUTHORS: Balzarini, J; Perez-Perez, MJ; San-Felix, A; Schols, D; Perno, CF; Vandamme, AM; Camarasa, MJ; De Clercq, E;
PUBLISHED: 1992, SOURCE: Proceedings of the National Academy of Sciences, VOLUME: 89, ISSUE: 10
410
TITLE: Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335.
AUTHORS: Witvrouw, M; Pauwels, R; Vandamme, AM; Schols, D; Reymen, D; Yamamoto, N; Desmyter, J; De Clercq, E;
PUBLISHED: 1992, SOURCE: Antimicrobial Agents and Chemotherapy, VOLUME: 36, ISSUE: 12
AUTHORS: Witvrouw, M; Pauwels, R; Vandamme, AM; Schols, D; Reymen, D; Yamamoto, N; Desmyter, J; De Clercq, E;
PUBLISHED: 1992, SOURCE: Antimicrobial Agents and Chemotherapy, VOLUME: 36, ISSUE: 12
